Names and pronunciation
(van-det′a-nib) Caprelsa
PDF page 1353
Drug reference
(van-det′a-nib) Caprelsa
PDF page 1353
Func. class.: Antineoplastic-tyrosine kinase inhibitor
PDF page 1353
USES: Treatment of metastatic/unre sectable locally-advanced medullary thyroid cancer
PDF page 1353
Black Box Warning: QTc prolongation
PDF page 1353
DOSAGE AND ROUTES • Adult: PO 300 mg daily, do not initiate treatment unless QTcF ≤450 msec
PDF page 1353
Available forms: Tabs 100, 300 mg Renal dose Adult: PO CCr ≥50 mL/min: No change; CCr 30-49 mL/min: Reduce starting dose to 200 mg and monitor QT interval; CCr <30 mL/min: Do not use
PDF page 1353
• Adult: PO 300 mg daily, do not initiate treatment unless QTcF ≤450 msec
PDF page 1353